| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
187 |
141 |
$7K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
38 |
30 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
41 |
29 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
43 |
32 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
93 |
63 |
$916.67 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
23 |
14 |
$810.17 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
35 |
30 |
$565.10 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
18 |
13 |
$494.86 |
| 36415 |
Collection of venous blood by venipuncture |
64 |
57 |
$301.82 |
| 99072 |
|
20 |
16 |
$0.00 |